303 related articles for article (PubMed ID: 8397447)
1. [Diseases of the female breast: clinical pathology].
Torhorst J
Ther Umsch; 1993 May; 50(5):307-13. PubMed ID: 8397447
[TBL] [Abstract][Full Text] [Related]
2. Definition of precancerous and high-risk mammary lesions.
Bégin LR
Can J Surg; 1985 May; 28(3):248-51. PubMed ID: 2986807
[TBL] [Abstract][Full Text] [Related]
3. [Pathology of premalignant and malignant diseases of the female breast].
Prechtel K
Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1989; ():897-900. PubMed ID: 2577661
[TBL] [Abstract][Full Text] [Related]
4. [Morphological diagnosis and prognosis in early ductal breast cancer].
Frank GA; Volchenko NN
Vopr Onkol; 1992; 38(3):299-310. PubMed ID: 1338666
[TBL] [Abstract][Full Text] [Related]
5. 17 beta-Hydroxysteroid dehydrogenase type 1 and type 2 in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.
Ariga N; Moriya T; Suzuki T; Kimura M; Ohuchi N; Satomi S; Sasano H
Anticancer Res; 2000; 20(2B):1101-8. PubMed ID: 10810403
[TBL] [Abstract][Full Text] [Related]
6. [Histopathology of the breast with reference to consultant studies. I. An analysis of 1,339 cases on the breast register of the Fulda Pathologic Institute].
Bässler R; Schneider B; Scheidt E
Pathologe; 1989 May; 10(3):135-41. PubMed ID: 2544865
[No Abstract] [Full Text] [Related]
7. Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised?
Middleton LP; Grant S; Stephens T; Stelling CB; Sneige N; Sahin AA
Mod Pathol; 2003 Feb; 16(2):120-9. PubMed ID: 12591964
[TBL] [Abstract][Full Text] [Related]
8. [Management of ductal carcinoma in situ by the pathologist: current questions].
Arnould L; Caron Y; Sigal-Zafrani B
Ann Pathol; 2003 Dec; 23(6):534-46. PubMed ID: 15094591
[TBL] [Abstract][Full Text] [Related]
9. [Breast cancer].
Van Bogaert LJ
Rev Fr Gynecol Obstet; 1984 May; 79(5):361-98. PubMed ID: 6098952
[No Abstract] [Full Text] [Related]
10. Pathologic considerations in the high-risk breast patient.
Simmons R; Serafin D; McCarty K
Clin Plast Surg; 1988 Oct; 15(4):655-65. PubMed ID: 2852084
[TBL] [Abstract][Full Text] [Related]
11. New aspects of the natural history of in situ and invasive carcinoma in the female breast. Results from autopsy investigations.
Andersen J; Nielsen M; Christensen L
Verh Dtsch Ges Pathol; 1985; 69():88-95. PubMed ID: 3006395
[No Abstract] [Full Text] [Related]
12. [Morphology, topography and growth pattern of benign proliferative breast lesions and pre-invasive cancers].
Böcker W; Jarasch ED; Nagle EB; Höhne R
Verh Dtsch Ges Pathol; 1985; 69():96-107. PubMed ID: 3006396
[No Abstract] [Full Text] [Related]
13. Clinical relevance of the distribution of the lesions in 500 consecutive breast cancer cases documented in large-format histologic sections.
Tot T
Cancer; 2007 Dec; 110(11):2551-60. PubMed ID: 17932896
[TBL] [Abstract][Full Text] [Related]
14. Pathology of high-risk breast lesions and ductal carcinoma in situ.
Sewell CW
Radiol Clin North Am; 2004 Sep; 42(5):821-30, v. PubMed ID: 15337418
[TBL] [Abstract][Full Text] [Related]
15. [Histopathology of the breast with reference to consultant studies. II. On the diagnosis and differential diagnosis of non-neoplastic diseases and tumors].
Bässler R; Kronsbein H; Schneider B
Pathologe; 1989 May; 10(3):142-59. PubMed ID: 2544866
[No Abstract] [Full Text] [Related]
16. Clinicopathologic analysis of breast lesions associated with multiple papillomas.
Ali-Fehmi R; Carolin K; Wallis T; Visscher DW
Hum Pathol; 2003 Mar; 34(3):234-9. PubMed ID: 12673557
[TBL] [Abstract][Full Text] [Related]
17. [Interobserver reproducibility in the pathologic diagnosis of borderline ductal proliferative breast diseases].
Wei B; Bu H; Zhu CR; Guo LX; Chen HJ; Zhao C; Zhang P; Chen DY; Tang Y; Jiang Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):849-53. PubMed ID: 15573772
[TBL] [Abstract][Full Text] [Related]
18. [Significance of hyperelastosis in proliferative lesions of the breast].
Cuccurullo L; Giordano GG; Mineo A; Iaccarino M; Battista O; Cattaneo L; Ferraraccio F
Pathologica; 1984; 76(1041):89-101. PubMed ID: 6087264
[No Abstract] [Full Text] [Related]
19. [Diagnostic immunohistochemistry of breast epithelial lesions].
Balaton AJ; Guinebretière JM; Penault-Llorca F
Ann Pathol; 2003 Dec; 23(6):570-81. PubMed ID: 15094595
[TBL] [Abstract][Full Text] [Related]
20. Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma.
Shin SJ; Simpson PT; Da Silva L; Jayanthan J; Reid L; Lakhani SR; Rosen PP
Am J Surg Pathol; 2009 Apr; 33(4):496-504. PubMed ID: 19047897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
